BATTLEFIELD WOUND INFECTION PREVENTION AND TREATMENT (BWI P&T): BARRIER COMBINATION PRODUCT DEVELOPMENT
Archived on February 4, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 2:00 PM EST
- Posted
- December 3, 2025
- Notice type
- Sources Sought
- Set-aside
- No Set aside used
- Agency
- Department of WarDEFENSE HEALTH AGENCY (DHA)
Notice details
- Office
- DEFENSE HEALTH AGENCY
- Place of performance
- Maryland, 21702
- Last updated
- Nov 5, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- HT9427-26-RFI-BWI-PT
- Notice ID
- 0f7bf84a247c425b970819fb5a0f4b60
Description
The Government is conducting market research to determine whether a commercial solution can be provided to meet requirements for battlefield wound infection prevention and treatment: barrier combination product. This market research may also assist with the further development and/or refinement of the requirements.
Objective and Purpose/Scope: DHA’s OPMED WPAC has a requirement to develop, deliver, and field medical products that address battlefield wounds and subsequent bacterial and fungal infections. The Battlefield Wound Infection Prevention and Treatment (BWI P&T) program is using a Family of Systems (FoS) approach that aims to develop multiple medical materiel solutions that are most relevant for use in austere environments where medical products may be limited and evacuation may be prolonged.
This RFI seeks responses to the barrier combination component of this FoS only.
Although there is an emphasis on use at the point of injury, this capability will likely be used across roles
of care spanning the austere battlefield environment to hospital care settings. The barrier combination product is
expected to be one of many components of the FoS that will provide novel solutions to the DoD and commercial
market with respect to wound care and infection prevention.
The barrier combination product must have the following minimum essential characteristics:
Please refer to Attachment 3 - Minimum Essential Characteristics (MECS)
North American Industry Classification System (NAICS) Code: Unknown
RFI Attachments: The following documents are attached to the RFI
- Attachment 1: Technical Readiness Level (TRL) (Reference Only)
- Attachment 2: Company & Product Information
- Attachment 3: Minimum Essential Characteristics (MECS)
- Response Due Date: Interested parties shall submit the RFI response electronically by 2:00pm Eastern on January 20, 2026, via e-mail to:
Please review Attachments 1, 2, and 3 as well as RFI for BWI PT Barrier Attachment for further instructions
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
Files (4)
- Download
A02 Attachment 3 - BWI PT Barrier Minimum Essential Characterics- Final 3 Dec 2025.docx
21 KBAdded in Sources Sought version 3Posted - Download
A02 Attachment 2 - Company Product Information - Final 3 Dec 2025.doc
40 KBAdded in Sources Sought version 3Posted - Download
Attachment 1 TRL-BWI PT Barrier.docx
24 KBAdded in Sources Sought version 3Posted - Download
A02 RFI for BWI PT Barrier - FInal 3 December 2025.docx
24 KBAdded in Sources Sought version 3Posted
Lifecycle
- 3Version 3Sources SoughtArchivedCurrent
BATTLEFIELD WOUND INFECTION PREVENTION AND TREATMENT (BWI P&T): BARRIER COMBINATION PRODUCT DEVELOPMENT
Similar Opportunities
No similar opportunities found
No similar opportunities match this opportunity's profile.
Additional Details
Solicitation Number
HT9427-26-RFI-BWI-PT
Archive Date
Feb 4, 2026
Office Address
FORT DETRICK, MD, 21702